Press Releases

Latest News

11-06-2019, Frankfurt, Germany

West and SCHOTT Announce Partnership to combine the SCHOTT iQ® Platform with West’s Ready Pack™ System

Supports Global Customers Seeking High-quality, Ready-to-use Packaging Products

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, and the international technology group SCHOTT, a leading primary packaging solutions provider, today announced a partnership to combine the SCHOTT iQ® platform with West’s Ready Pack™ system. The collaboration will initially launch by combining West components and SCHOTT’s adaptiQ® high-quality RTU glass vials and will expand to include other convenient, ready-to-use combinations of West and SCHOTT products, to be available on a small-quantity basis. The companies made the announcement at the CPhI Worldwide conference, and shared plans to expand West’s Ready Pack system to include additional SCHOTT glass offerings— including more vial formats as well as ready-to-use cartridges (cartriQ™) and pre-fillable glass syringes (syriQ®). Further product launch plans will be shared at the Pharmapack meeting in early 2020.
West and SCHOTT Announce Partnership to combine the SCHOTT iQ® Platform with West’s Ready Pack™ System
West and SCHOTT Announce Partnership to combine the SCHOTT iQ® Platform with West’s Ready Pack™ System
“With more than 4,000 new injectable drug products in development worldwide, many of which are in small settings such as universities, medical research institutes, or smaller-sized companies, West appreciates and understands the need to provide ready-to-use, high quality, sterile packaging products in small volumes for developmental and clinical phases,” said Mike Schaefers, Ph.D., Vice President and General Manager, Pharma, West. “Our partnership with SCHOTT now provides our customers with high-quality glass containment options to complement the stoppers, seals and glass alternatives West already provides through its Ready Pack system.”

“Easy and fast access to our broad product portfolio of ready-to-use vials and components not only gives flexibility in the drug development and production process, but also helps to enhance patient’s safety as an overall target,” said Fabian Stöcker, VP, Global Strategy and Innovation, SCHOTT Pharmaceutical Systems. He added, “Through this partnership, SCHOTT and West have partnered to provide containment solutions to the market that reduce risk and meet the increasing regulations across the globe. We worked together to pre-test combinations of SCHOTT’s highest quality ISO vials, with WEST’s high-end sterilized stoppers and seals. Extending this concept to other primary packaging containers such as ready-to-use cartridges and ready-to-use syringes will also benefit our customers using this kind of primary packaging.”

West’s Ready Pack system consists of sterilized NovaPure® stoppers, Flip-Off® CCS seals and SCHOTT’s adaptiQ® vials. Ready Pack components are provided ready-to-use, from stock, so they are prepared to ship when customers place their order. The combination of West and SCHOTT products is well-suited for Research and Development purposes or for small filling operations.   The Ready Pack system is also scalable, designed to support a smooth transition from early-stage pilot manufacture to larger commercial-scale operations. All Ready Pack components have been tested and proven fit-for-use. This is supported by comprehensive technical data reports, including container closure integrity data, to support manufacturers in their development.   West’s Ready Pack system is available to order via West’s online store.

SCHOTT’s adaptiQ® vials were developed in cooperation with innovative and highly regarded machine suppliers. The vials will be available in various formats with different sterile packaging options such as the clip nest, cup nest and tray solution and can be processed on a wide range of existing and new fill and finish equipment. Nested processing of the vials ensures no glass-to-glass contact of the vials throughout the fill finish process including lyophilization.

Forthcoming combinations of the products within the Ready Pack and SCHOTT iQ® platforms will extend to customizable configurations in order to meet various requirements, whether changing batch sizes or accommodating different container needs, especially for biologic drugs.  In the near future, West and SCHOTT look forward to growing this partnership through more combined high-quality product offerings leveraging the SCHOTT iQ® portfolio as well as a range of West and Daikyo proprietary packaging components in response to the needs of global customers and ultimately, serving patients. 
West and the diamond logo, Ready Pack™, Flip-Off®, and NovaPure® are trademarks and registered trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions. 
SCHOTT iQ®, adaptiQ®, syriQ® are registered trademarks of SCHOTT AG.

Media & Product Information Contacts
Members of the companies will be attending CPhI Worldwide in Frankfurt from 5-7 November 2019. To request information on the partnership, please contact:

Press contact:
Matt McLoughlin
Gregory FCA on behalf of SCHOTT
Phone: 610-228-2123

Rina Della Vecchia
SCHOTT North America, Inc.
Office: 914-831-2286

For West Ready Pack®:
Media contact:
Emily Denney
Global Communications

SCHOTT Pharmaceutical Systems is a leading supplier of primary pharma packaging and analytical lab services. We provide quality solutions while meeting the highest demands. Our product portfolio includes ampoules, syringes, cartridges and vials as well as various polymer solutions. Furthermore, we are constantly improving our products and offer individual customer solutions to remain on top of the market’s needs. Our lab analytics experts offer a wide variety of lab services for pharmaceutical packaging to our customers in finding solutions to their most challenging packaging requirements. Our production facilities and products comply with the highest international standards for pharmaceutical needs.

SCHOTT is a leading international technology group in the areas of specialty glass, glass-ceramics and related high-tech materials. With over 130 years of experience, the company is an innovative partner to many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive and aviation industries. SCHOTT has a global presence with production sites and sales offices in 34 countries. In the 2017/2018 fiscal year, the group generated sales of around $2.5 billion with over 15,500 employees.

About West:
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West’s products and services address the unique needs of our Biologics, Pharmaceutical, Generics and Contract Manufacturing customers. The Company also offers an Integrated Solutions Program—a comprehensive approach that combines West’s high-quality packaging and delivery products with expert analytical testing, device manufacturing and assembly, and regulatory expertise.

West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2018 net sales of $1.7 billion reflect the daily use of approximately 112 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world. For more information, visit
Exhibitions & Events
Exhibition Denkmal, Leipzig, Germany, 11-05 to 11-07-2020
Exhibition 3rd China International Import Expo (CIIE), Shanghai, China, 11-05 to 11-11-2020
Exhibition CIAAR - Auto Air-conditioning & Transport Refrigeration Expo, Shanghai, China, 11-12 to 11-14-2020
SCHOTT uses Cookies on this Website to enhance the user experience and provide the best possible Service. By continuing to browse the Website, you consent to our use of Cookies.